Showing results (1531-1540 of 1,560) with videos related to

Sort By:
Pageof 156
Cardiovascular Endocrinology & Metabolism|October 2, 2023
The concomitant use of sodium-glucose co-transporter 2 inhibitors improved the renal outcome of Japanese patients with type 2 diabetes treated with glucagon-like peptide 1 receptor agonistsKazuo Kobayashi, Masao Toyoda, Nobuo Hatori, et al.
The Journal of Obstetrics and Gynaecology Research|November 4, 2020
Guideline for Gynecological Practice in Japan: Japan Society of Obstetrics and Gynecology and Japan Association of Obstetricians and Gynecologists 2020 editionRyuji Kawaguchi, Koji Matsumoto, Tetsuya Ishikawa, et al.
Ebiomedicine|March 23, 2024
High-throughput screening of small-molecules libraries identified antibacterials against clinically relevant multidrug-resistant A. baumannii and K. pneumoniaeBenjamin Blasco, Soojin Jang, Hiroki Terauchi, et al.
Cardiovascular Diabetology|August 29, 2019
Improved home BP profile with dapagliflozin is associated with amelioration of albuminuria in Japanese patients with diabetic nephropathy: the Yokohama add-on inhibitory efficacy of dapagliflozin on albuminuria in Japanese patients with type 2 diabetes study (Y-AIDA study)Sho Kinguchi, Hiromichi Wakui, Yuzuru Ito, et al.
Nature Communications|September 21, 2021
A novel nairovirus associated with acute febrile illness in Hokkaido, JapanFumihiro Kodama, Hiroki Yamaguchi, Eunsil Park, et al.
Journal of Clinical Medicine Research|April 16, 2016
Factors Influencing Changes in Hemoglobin A1c and Body Weight During Treatment of Type 2 Diabetes With Ipragliflozin: Interim Analysis of the ASSIGN-K StudyKotaro Iemitsu, Takashi Iizuka, Masahiro Takihata, et al.
Journal of Diabetes Investigation|May 21, 2014
Efficacy and safety of sitagliptin monotherapy and combination therapy in Japanese type 2 diabetes patientsAkira Kubota, Hajime Maeda, Akira Kanamori, et al.
Journal of Clinical Medicine Research|October 2, 2012
Pleiotropic effects of sitagliptin in the treatment of type 2 diabetes mellitus patientsAkira Kubota, Hajime Maeda, Akira Kanamori, et al.
JCI Insight|September 8, 2023
Hepatic FASN deficiency differentially affects nonalcoholic fatty liver disease and diabetes in mouse obesity modelsToshiya Matsukawa, Takashi Yagi, Tohru Uchida, et al.
Nature Genetics|February 13, 1999
Increased insulin sensitivity and hypoglycaemia in mice lacking the p85 alpha subunit of phosphoinositide 3-kinaseY Terauchi, Y Tsuji, S Satoh, et al.
Pageof 156